| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.034 | 0.4 |